Form 4: Allstate CEO Sells Shares Under Pre-Arranged 10b5-1 Plan

Allstate Corporation's Chairman, President, and CEO, Thomas J. Wilson, sold 16,807 shares of common stock on October 20, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Thomas J. Wilson, Chairman, President & CEO, and Director of The Allstate Corporation, reported the sale of 16,807 shares of common stock.
• The sales occurred on October 20, 2025, and were executed pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2025.
• The shares were sold in multiple transactions at weighted average prices ranging from $193.6903 to $196.5001 per share.
• Following these transactions, Mr. Wilson directly beneficially owns 195,233.491 shares of Common Stock.
• Indirect beneficial ownership includes 111,442 shares via 2023-B GRAT, 65,321 shares via 2024-C GRAT, 69,822 shares via 2025-A GRAT, 7,647 shares via 401(k) Plan, 273,954 shares via 2020 GRAT Remainder Trust, and 257,535 shares via Remainder GRAT.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the fact that these sales were conducted under a pre-arranged Rule 10b5-1 plan mitigates any concerns about management's confidence in the company's future, making it a routine financial event.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, which demonstrates transparency and adherence to best practices for insider transactions, mitigating concerns about trading on material non-public information.

Negatives

• Insider selling, even when pre-planned, can sometimes be perceived negatively by investors as it represents a reduction in direct ownership by a key executive.

Risks

• No specific risks are mentioned in this Form 4 filing beyond the general market perception associated with insider selling, which is mitigated by the 10b5-1 plan.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

Insider transactions, particularly sales by senior executives, are a routine aspect of corporate finance. The use of a Rule 10b5-1 plan is a standard practice in the industry, allowing executives to diversify their personal holdings or manage liquidity over time in a pre-scheduled manner, thereby avoiding accusations of trading on inside information.

Comparison to Industry Standards

• The execution of stock sales by a CEO under a Rule 10b5-1 plan is a common and accepted practice among publicly traded companies and their executives, aligning with corporate governance best practices for managing insider transactions transparently.
• Many executives across various industries, including insurance, utilize such plans to manage their equity compensation and personal financial planning, similar to practices observed at companies like Travelers (TRV) or Progressive (PGR).

Stakeholder Impact

• Shareholders may note the reduction in direct ownership by the CEO, but the pre-arranged nature of the sales via a 10b5-1 plan should prevent significant concerns regarding management's long-term commitment or outlook for the company.

Key Dates

Recommendation

The filing reports a routine, pre-scheduled sale of shares by the CEO under a Rule 10b5-1 plan. This type of transaction is common for executives to manage personal finances and diversify holdings and does not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. Investors should continue to evaluate Allstate based on its financial performance, strategic initiatives, and broader market conditions.

Keywords

Allstate, ALL, Thomas J. Wilson, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, CEO, Director, Executive Compensation